The clinical use of epoxypiperazine, a new alkylating agent, in the treatment of lymphomas and other neoplasms.
D000477:Alkylating Agents; D000970:Antineoplastic Agents / Q000628:therapy*; D008223:Lymphoma / Q000628:therapy*; D009369:Neoplasms; D010879:Piperazines / Q000628:therapy*
D000477:Alkylating Agents; D000970:Antineoplastic Agents; D010879:Piperazines
ANTINEOPLASTIC AGENTS/therapy; LYMPHOMA/therapy; PIPERAZINES/therapy